Felix Mick Brachytherapy Award given to young radiation oncologists

| Source: Eckert & Ziegler BEBIG Eckert & Ziegler BEBIG

Seneffe, Belgium, June 14, 2018. Today, Eckert & Ziegler BEBIG presented the Felix Mick Brachytherapy Award to two young radiation oncologists, both of whom are dedicated to using radiation therapy for the treatment of prostate cancer. The presentation of the award took place during the ESTRO Teaching Course: Brachytherapy for Prostate Cancer in Avignon, France.

Felix Mick Brachytherapy Award winners Andreia Ponte, M.D. and Dr. Jose A. Domínguez Rullán with Dr. Adina Esterlin, Eckert & Ziegler BEBIG Area General Manager

The prize enabled the winners to participate in the ESTRO Teaching Course: Brachytherapy for Prostate Cancer, where they deepened their knowledge regarding patient selection, indications and contra-indications for brachytherapy, and the techniques, equipment and staffing necessary for a prostate brachytherapy unit. The winners were chosen in cooperation with the Young ESTRO Committee (yESTRO) and the Spanish Young Radiation Oncology Group (SYROG).

The prize named to honor Felix Mick, founder of Mick Radio-Nuclear Instruments, Inc. in Mount Vernon, New York (USA), was awarded for the first time and aims to support young radiation oncologists in their continuing training. Motivated by the excellent treatment results achieved by brachytherapy specialists all over the world, Eckert & Ziegler BEBIG is committed to the treatment of prostate cancer using high-quality HDR and LDR brachytherapy equipment. "We wish to show our appreciation to all of our specialists for their professionalism, dedication and above all for their contributions, which have led to improved treatment quality and administration of brachytherapy in clinics. This year we would like to express our gratitude by supporting the next generation of brachytherapists," stated Dr. Harald Hasselmann, Managing Director of Eckert & Ziegler BEBIG and Member of the Board of Directors of Eckert & Ziegler AG.

About Mick Radio-Nuclear Instruments

Mick Radio-Nuclear Instruments, Inc., known internationally for its 40 years of service to the radiation therapy and brachytherapy communities, provides the highest-quality and state-of-the-art brachytherapy technology to confront the challenges faced in the fight against cancer. The company's involvement in prostate and gynecological brachytherapy has resonated throughout the world. It remains today a strong and viable technology with proven excellent clinical outcomes at a reasonable cost. Mick Radio-Nuclear Instruments is committed to using its 40 years of manufacturing experience in the field of brachytherapy to best serve the special needs that we are often confronted with.
 
In 2013, European based Eckert & Ziegler BEBIG acquired Mick Radio-Nuclear Instruments, Inc.

About Eckert & Ziegler BEBIG
My partner in brachytherapy and radiation therapy
Eckert & Ziegler BEBIG is a European-based group active in the medical device segment of the healthcare industry. Its core business is the production and distribution of medical products for the treat­ment of cancer, using brachytherapy. The company's headquarters are in Belgium, with production facilities in Germany and the USA, as well as subsidiaries throughout Europe, the USA, India and Brazil. In addition, Eckert & Ziegler BEBIG has a worldwide network of distributors and agents to support the international marketing and distribution of its product line. The company's products and equipment are intended for use by oncologists, radiotherapists, urologists, ophthalmologists and medical physicists.

Eckert & Ziegler BEBIG employs approximately 145 people. The company has been listed on the Euronext stock exchange since April 1997.

Contact:
Annica Witt
Marketing Communication Manager
marketing@bebig.com
www.bebig.com